Read + Share
Amedeo Smart
Independent Medical Education
Gupta S, Lee JK, Mitchell J, Huang RSP, et al. Fibroblast Growth Factor Receptor 3 Alteration Status and Outcomes on Immune Checkpoint Inhibitors in Patients With Metastatic Urothelial Carcinoma. JCO Precis Oncol 2025;9:e2500257.PMID: 40956998
Email
LinkedIn
Privacy Policy